Aspect Partners’s Eikon Therapeutics EIKN Stock Holding History
Bought
Maintained
Sold
Other funds holding EIKN
PFSRSONJ
IA
FFO
SS
Aspect Partners's EIKN Position: Q2 2026 in Review
Aspect Partners opened a new position in Eikon Therapeutics (EIKN) in Q2 2026: 126 shares worth $1.64K. The stake represents ﹤0.01% of the portfolio and ranks #527 among its holdings.
5 funds tracked by Wall St. Rank hold EIKN as of Q2 2026.
- Aspect Partners held 126 shares of Eikon Therapeutics worth $1.64K as of Q2 2026.
- Eikon Therapeutics was a new Aspect Partners position in Q2 2026.
- Eikon Therapeutics made up ﹤0.01% of Aspect Partners's portfolio in Q2 2026, its #527 holding.
- 5 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q2 2026.
Based on Aspect Partners's 13F filing for Q2 2026, filed 16 Jul 2026.